FLOTAXL

Paclitaxel Injection IP 30mg/100mg/260mg

DESCRIPTION

Interferes with mitotic spindle by binding to beta tubulin that
prevent microtubule depolymerization in G2/M phase of the
cell cycle & increases Apoptosis of tumor cells.

Description

FLOTAXL USE TO TREATĀ Breast Cancer (BC):

Non-Small Cell Lung Cancer (NSCLC)

Hormone Refractory Prostate Cancer (HRPC)

Gastric Adenocarcinoma (GC)

Squamous Cell Carcinoma of the Head and Neck Cancer (SCCHN)

It binds to the B-subunit of tubulin & interferes with the microtubule’s segregation to daughter cellsĀ  by causing hyper-polymerization of microtubules in the G2/M-phase of cell division

Reviews

There are no reviews yet.

Be the first to review “FLOTAXL”

Your email address will not be published. Required fields are marked *